Literature DB >> 24624456

PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.

Yingfei Zhang, Jianlong Zhang, Kang Xu, Zhiyu Xiao, Jian Sun, Junyao Xu, Jie Wang, Qibing Tang.   

Abstract

BACKGROUND/AIMS: Patients of Pancreatic Cancer with B7-H1 over-expression usually have a poor prognosis. In our previous study, the expression of PTEN and B7-H1 were significantly correlated to the carcinogenesis in pancreatic carcinoma. In this study, we investigated the role of the PTEN/mTOR/B7-H1 pathway in immune-resistance, immune escape and progression of pancreatic cancer.
METHODOLOGY: siRNAs targeting PTEN were designed, and transfected into pancreatic cancer cell lines. Transwell chamber invasion assay, CCK-8 proliferation assay and siRNA interference assay were used to explore the effect of PTEN on PI3K signaling. Expression of protein and mRNA of the factors involved in PTEN/mTOR/B7-H1 pathway were examined by RT-PCR and Western blot. T Cells apoptosis assay were performed by flow cytometer.
RESULTS: Our study demonstrated that B7-H1 was regulated by PTEN through the PI3K/AKT pathway. Loss of PTEN promoted cell proliferation, cell invasion and led to significant increases in the levels of Phospho-AKT, Phospho-mTOR, phospho-S6K1 and B7-H1 proteins. In addition, the increased expression level of B7-H1 when PTEN was knockdown induced T lymphocyte apoptosis.
CONCLUSION: Our results demonstrated deletion of PTEN in pancreatic cancer cells induced the expression of B7-H1, which contributed to immune suppression and increased cancer progression and invasion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24624456

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  19 in total

1.  Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.

Authors:  Gang-Gang Mu; Ling-Li Zhang; Hong-Yan Li; Yan Liao; Hong-Gang Yu
Journal:  Dig Dis Sci       Date:  2014-10-26       Impact factor: 3.199

2.  PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.

Authors:  Xiaohui Zhang; Yuanyuan Zeng; Qiuxia Qu; Jianjie Zhu; Zeyi Liu; Weiwei Ning; Hui Zeng; Nan Zhang; Wenwen Du; Cheng Chen; Jian-An Huang
Journal:  Int J Clin Oncol       Date:  2017-07-26       Impact factor: 3.402

3.  Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.

Authors:  Selvi Kunnimalaiyaan; Jose Trevino; Susan Tsai; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal:  Mol Cancer Ther       Date:  2015-04-17       Impact factor: 6.261

4.  Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.

Authors:  Ming-Xiang Zou; An-Bo Peng; Guo-Hua Lv; Xiao-Bin Wang; Jing Li; Xiao-Ling She; Yi Jiang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

5.  Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.

Authors:  Gijung Kwak; Dongkyu Kim; Gi-Hoon Nam; Sun Young Wang; In-San Kim; Sun Hwa Kim; Ick-Chan Kwon; Yoon Yeo
Journal:  ACS Nano       Date:  2017-10-12       Impact factor: 15.881

6.  Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Authors:  Anna Sophie Berghoff; Barbara Kiesel; Georg Widhalm; Orsolya Rajky; Gerda Ricken; Adelheid Wöhrer; Karin Dieckmann; Martin Filipits; Anita Brandstetter; Michael Weller; Sebastian Kurscheid; Monika E Hegi; Christoph C Zielinski; Christine Marosi; Johannes A Hainfellner; Matthias Preusser; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2014-10-29       Impact factor: 12.300

7.  miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.

Authors:  Marissa Williams; Michaela B Kirschner; Yuen Yee Cheng; Jacky Hanh; Jocelyn Weiss; Nancy Mugridge; Casey M Wright; Anthony Linton; Steven C Kao; J James B Edelman; Michael P Vallely; Brian C McCaughan; Wendy Cooper; Sonja Klebe; Ruby C Y Lin; Himanshu Brahmbhatt; Jennifer MacDiarmid; Nico van Zandwijk; Glen Reid
Journal:  Oncotarget       Date:  2015-09-15

8.  B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells.

Authors:  Yidan Zhi; Zhirong Mou; Jun Chen; Yujun He; Hui Dong; Xiaolan Fu; Yuzhang Wu
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

9.  PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.

Authors:  Narinder Sharma; Rajesh Nanta; Jay Sharma; Sumedha Gunewardena; Karan P Singh; Sharmila Shankar; Rakesh K Srivastava
Journal:  Oncotarget       Date:  2015-10-13

10.  The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures.

Authors:  Ziying Lin; Yutong Xu; Yaxiong Zhang; Qihua He; Jianrong Zhang; Jianxing He; Wenhua Liang
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.